Researchers examined the effects of Lipitor on mice at different stages of a disease similar to MS. They found the drug improved symptoms in all three groups.
During the early and acute stages of the disease, the drug appeared to lessen paralysis. The most dramatic results were seen in mice with the most common form of MS, known as Relapsing-Remitting. The Stanford researchers say the drug appeared to halt the progression of these flare ups.
Researchers want to study the drug in humans now to see if Lipitor could be used to prevent MS from developing in people who have had a first attack. Three types of drugs are currently approved to treat Multiple Sclerosis, all are administered by injection. Lipitor is taken orally. This study was conducted at the University of California at San Francisco and Stanford University. It is published in the Journal "Nature."